Interleukin-17A (IL-17A): A silent amplifier of COVID-19
One of the hallmarks of COVID-19 is the cytokine storm that provokes primarily pneumonia followed by systemic inflammation. Emerging evidence has identified a potential link between elevated interleukin-17A (IL-17A) levels and disease severity and progression. Considering that per se, IL-17A can act...
Main Authors: | Francesco Maione, Gian Marco Casillo, Federica Raucci, Cristian Salvatore, Giovanna Ambrosini, Luisa Costa, Raffaele Scarpa, Francesco Caso, Mariarosaria Bucci |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221007629 |
Similar Items
-
“Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting”
by: Francesco Maione
Published: (2016-08-01) -
Identification and Regulation of Interleukin-17 (IL-17) Family Ligands in the Teleost Fish European Sea Bass
by: Carmen González-Fernández, et al.
Published: (2020-03-01) -
Role of Interleukin-17 in Acute Pancreatitis
by: Guanqun Li, et al.
Published: (2021-09-01) -
Distinct roles of interleukin-17 and T helper 17 cells among autoimmune diseases
by: Shintaro Akiyama, et al.
Published: (2021-01-01) -
Expression of T helper 17 cells and interleukin 17 in lupus nephritis patients
by: Nayera Z. Saber, et al.
Published: (2017-07-01)